Copyright
©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3158-3166
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3158
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3158
Table 4 The value of ubiquitin carboxy-terminal hydrolase L1 and glial fibrillary acidic protein levels for predicting postoperative recurrence of glioma
Indicator | Critical value | AUC | 95%CI | P value | Sensitivity (%) | Specificity (%) |
Preoperative UCH-L1 | 103.85 | 0.785 | 0.670-0.901 | < 0.001 | 68.2 | 81.2 |
3 d after surgery UCH-L1 | 85.61 | 0.646 | 0.507-0.785 | 0.040 | 63.6 | 62.3 |
Preoperative GFAP | 18.70 | 0.775 | 0.651-0.898 | < 0.001 | 63.6 | 88.4 |
3 d after surgery GFAP | 8.58 | 0.648 | 0.508-0.787 | 0.038 | 59.1 | 75.4 |
- Citation: Zhu QH, Wu JK, Hou GL. Changes and significance of serum ubiquitin carboxyl-terminal hydrolase L1 and glial fibrillary acidic protein in patients with glioma. World J Clin Cases 2023; 11(14): 3158-3166
- URL: https://www.wjgnet.com/2307-8960/full/v11/i14/3158.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i14.3158